illumax
Latest round
- Series A
Last raised
- May 2023
Total raised
- Undisclosed
Investors
- 4
About illumax
Based in Chengdu, China, and founded in 2018, illumax operates as a provider of clinical immune and molecular diagnostic systems, specializing in the development of single-component luminescent flow-through platforms. The company has an industrial base of nearly 4,000 square meters in Chengdu International Medical City. The main products have been awarded NMPA certification and European CE certification. The company's fully automated POCT chemiluminescence is certified in 2020. The company specializes in the development and manufacture of single-component chemiluminescence, single-component flow-through fluorescence and laboratory automation products, and provides an open ecological platform for chemiluminescence and flow-through fluorescence. The company's main products are the fully automated flow-through fluorescence immunoassay P16, the single-component chemiluminescence immunoassay lumilite8 and the fully automated chemiluminescence immunoassay lumiflx16. The products can be used in scenarios such as laboratory departments, ICUs, emergency departments, cardiology departments, chest pain centers, emergency vehicles and clinics at all levels of healthcare.
Who invested in illumax
4 investors across 2 rounds
See all investors in illumax
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about illumax
Who invested in illumax?
illumax has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has illumax raised?
illumax has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did illumax last raise money?
illumax's most recent round on record is a Series A, in May 2023.
What does illumax do?
Based in Chengdu, China, and founded in 2018, illumax operates as a provider of clinical immune and molecular diagnostic systems, specializing in the development of single-component luminescent flow-through platforms.
Where is illumax headquartered?
illumax is headquartered in Chengdu, China.
Which VCs invest in companies like illumax?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at illumax's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like illumax? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.